Mechelen, Belgium; February 17, 2025, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification and 13D filing from Tang...
Compelling clinical results for GLPG5101 in three NHL indications underscore potential of innovative decentralized cell therapy platform to deliver fresh, fit cells, in median seven...
Overtuigende klinische resultaten voor GLPG5101 in drie NHL-indicaties onderstrepen het potentieel van het innovatieve gedecentraliseerde celtherapieplatform voor de levering van verse, fitte cellen met een...
Galapagos intends to create a new company with approximately €2.45 billion in cash dedicated to building a pipeline of innovative medicines through transformational transactions Galapagos...